Latest News

Most readers would already be aware that Aecon Group's (TSE:ARE) stock increased significantly by 28% over the past...

Despite an already strong run, Transcat, Inc. ( NASDAQ:TRNS ) shares have been powering on, with a gain of 27% in the...

Tredegar Corporation ( NYSE:TG ) shares have continued their recent momentum with a 26% gain in the last month alone...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Despite an already strong run, CES Energy Solutions Corp. ( TSE:CEU ) shares have been powering on, with a gain of 31...

Crescent Energy Company ( NYSE:CRGY ) shareholders would be excited to see that the share price has had a great month...

While Taylor Devices, Inc. ( NASDAQ:TAYD ) might not have the largest market cap around , it received a lot of...

Despite an already strong run, Pangaea Logistics Solutions Ltd. ( NASDAQ:PANL ) shares have been powering on, with a...

To the annoyance of some shareholders, Reitar Logtech Holdings Limited ( NASDAQ:RITR ) shares are down a considerable...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

The BlueLinx Holdings Inc. ( NYSE:BXC ) share price has done very well over the last month, posting an excellent gain...

i3 Verticals (IIIV) opened fiscal Q1 2026 with revenue of US$52.7 million and basic EPS of US$0.03, while net income excluding extra items came in at US$0.6 million. The company has seen quarterly revenue move between US$46.2 million and US$61.7 million over the past two years, with basic EPS ranging from a loss of US$0.58 to a profit of US$0.54. This latest print lands in the middle of its recent earnings range and keeps the focus firmly on how margins are evolving from here. See our full...

Fluence Energy (FLNC) is in focus after first quarter earnings showed revenue of US$475.23 million compared with US$186.79 million a year earlier, alongside a wider net loss and reaffirmed full year revenue guidance. See our latest analysis for Fluence Energy. The latest earnings release and reaffirmed guidance arrived after a volatile stretch for the stock, with a 7 day share price return of a 36.82% decline and a year to date share price return of a 15.52% decline. At the same time, the 1...

There's no doubt that investing in the stock market is a truly brilliant way to build wealth. But if you choose that...

Vermilion Energy Inc. ( TSE:VET ) shareholders would be excited to see that the share price has had a great month...

Synaptics (SYNA) just posted Q2 2026 results with revenue of US$302.5 million and a basic EPS loss of US$0.38, while net income excluding extra items came in at a loss of US$14.8 million, keeping profitability under pressure. Over the past few quarters, revenue has moved from US$267.2 million in Q2 2025 to US$266.6 million in Q3, US$282.8 million in Q4, US$292.5 million in Q1 2026 and now US$302.5 million. Over the same period, EPS has swung from a small profit of US$0.05 in Q2 2025 to losses...

Volvo Car AB (publ.) (OM:VOLCAR B) closed FY 2025 with Q4 revenue of SEK 94.4b and basic EPS of SEK 0.43, set against a trailing twelve month EPS of SEK 0.06 and net income of SEK 174m that highlight how thin reported profitability has been over the year. Over recent quarters, revenue has moved between SEK 82.9b and SEK 112.1b while basic EPS has ranged from a loss of SEK 2.53 in Q2 2025 to SEK 1.75 in Q3 2025. This gives investors a wide spread of outcomes to weigh as they assess the latest...

Why Celestica is on investors’ radar today Celestica (TSX:CLS) is drawing interest after recent trading moves, with the share price showing mixed short term performance that contrasts with its stronger longer term total returns for shareholders. See our latest analysis for Celestica. Recent trading has been choppy, with a 1-day share price return of 4.67% and 7-day return of 9.67% contrasting with a 90-day share price decline of 7.08%. The 1-year total shareholder return of 126.5% suggests...

ConocoPhillips (COP) has just wrapped up FY 2025 with Q4 revenue of US$13.7b and basic EPS of US$1.17, alongside net income excluding extra items of US$1.4b. This puts fresh numbers on the table for investors watching its earnings power. Over recent quarters, the company has seen revenue move from US$14.7b and EPS of US$1.90 in Q4 2024 to a FY 2025 trajectory that includes US$16.9b of revenue and EPS of US$2.23 in Q1 2025, before settling at the latest Q4 run rate. With trailing 12 month net...

Micron Technology has broken ground on a new US$24b advanced wafer fabrication plant in Singapore. The facility is focused on next generation NAND production aimed at rising AI driven data storage demand. The project includes plans for advanced automation, sustainability features, and workforce development in a key semiconductor hub. For investors tracking Micron Technology (NasdaqGS:MU), this Singapore build out comes at a time when the stock is trading around US$394.69. The company has...

DNOW Inc. ( NYSE:DNOW ) shareholders have had their patience rewarded with a 28% share price jump in the last month...

Coloplast (CPSE:COLO B) is back in focus after reporting first quarter results that showed organic revenue and EBIT growth, while also confirming guidance for around 7% EBIT growth in constant currencies for 2025-2026. See our latest analysis for Coloplast. Despite the solid Q1 update and confirmed guidance, sentiment around Coloplast has been weak. The 30 day share price return of 12.34% and 1 year total shareholder return of 34.73% are both firmly negative, pointing to fading momentum...

Cousins Properties (CUZ) has wrapped up FY 2025 with Q4 revenue of US$261.2 million and a basic EPS loss of US$0.02, alongside a funds from operations loss of US$358.9 million that puts the quarter firmly in the red for shareholders. Over recent periods, the company has seen revenue move from US$223.3 million in Q4 2024 to US$248.4 million in Q1 2025 and US$238.5 million in Q2 2025 before reaching US$245.6 million in Q3 2025, while quarterly basic EPS ranged from earnings of US$0.12 in Q1...

Ardelyx recently announced dosing of the first patient in ACCEL, a Phase 3 trial of IBSRELA (tenapanor) in adults with chronic idiopathic constipation, while also securing a new U.S. patent extending oral formulation protection for IBSRELA and XPHOZAH to 2042. The combination of advancing IBSRELA into a large new indication and lengthening patent protection may reshape how long Ardelyx’s medicines can remain differentiated in the market. With the new 2042 formulation patent as a backdrop,...